ARS

USFDA declines to approve ARS' emergency nasal spray for allergic reactions

ARS Pharma was seeking approval for the nasal spray treatment, Neffy, as an emergency treatment of allergic reactions including anaphylaxis, in adults and children who weigh more than 30 kg.